$599

Novo’s Awiqli Receives FDA Approval; Oral Wegovy Discount Price Extension; Kailera Ph2 Obesity Study; Ionis Cuts TRYNGOLZA WAC Price

A series of cardiometabolic-related news items has been observed from Novo Nordisk, Kailera, and Ionis Pharmaceuticals. Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Register
Already a member? Log in here